Literature DB >> 35193028

Association of Carotid Intima-Media Thickness with Brain MRI Markers in the Atherosclerosis Risk in Communities Neurocognitive Study (ARIC-NCS).

Wendy Wang1, Faye L Norby2, Alvaro Alonso3, Rebecca F Gottesman4, Clifford R Jack5, Michelle L Meyer6, David S Knopman7, Kevin J Sullivan8, Timothy M Hughes9, Kamakshi Lakshminarayan10, Pamela L Lutsey11.   

Abstract

OBJECTIVE: Elevated carotid intima-media thickness (cIMT) and carotid plaque are markers of arterial injury and may be linked to structural brain injury. We hypothesized cIMT or presence of carotid plaque at midlife are associated with presence of infarcts and cerebral microbleeds, greater white matter hyperintensity (WMH) volume, and smaller regional brain volumes in late-life.
METHODS: We included 1,795 Atherosclerosis Risk in Communities (ARIC) Study participants (aged 57±6 years, 57% female, 23% Black) with carotid ultrasounds in 1990-1992 and brain MRI scans in 2011-2013. Weighted linear regression was used for brain volume outcomes, while logistic regression was used for infarcts and cerebral microbleeds.
RESULTS: After multivariable adjustments, the highest cIMT quintile was associated with smaller deep gray matter (β [95% CI]: -0.11 [-0.22, -0.01]) and cortical volume in a temporal-parietal meta region of interest (ROI) (β [95% CI]: -0.10 [-0.20, -0.01]) in late-life. Similarly, those with carotid plaque had smaller regional brain volumes than those without (βs [95% CIs]: -0.05 [-0.12, 0.03] and -0.06 [-0.13, 0.01] for deep gray matter and temporal-parietal meta ROI). No significant relations were observed with WMH volume, infarcts, or cerebral microbleeds.
CONCLUSION: Over a median follow-up of 21 years, greater midlife cIMT and presence of carotid plaque were associated with smaller deep gray matter volume and cortical volume in a meta ROI involving temporal and parietal lobe regions typically involved in neurodegeneration, including Alzheimer's disease, in later life. Contrary to our hypothesis, associations between measures of arterial injury and markers of vascular brain injury were null.
Copyright © 2022 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Brain imaging; Carotid intima-media thickness; Carotid plaque; Epidemiology

Mesh:

Substances:

Year:  2022        PMID: 35193028      PMCID: PMC9018472          DOI: 10.1016/j.jstrokecerebrovasdis.2022.106388

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.677


  43 in total

1.  Carotid artery atherosclerosis, MRI indices of brain ischemia, aging, and cognitive impairment: the Framingham study.

Authors:  José R Romero; Alexa Beiser; Sudha Seshadri; Emelia J Benjamin; Joseph F Polak; Ramachandran S Vasan; Rhoda Au; Charles DeCarli; Philip A Wolf
Journal:  Stroke       Date:  2009-03-05       Impact factor: 7.914

2.  Accounting for bias due to selective attrition: the example of smoking and cognitive decline.

Authors:  Jennifer Weuve; Eric J Tchetgen Tchetgen; M Maria Glymour; Todd L Beck; Neelum T Aggarwal; Robert S Wilson; Denis A Evans; Carlos F Mendes de Leon
Journal:  Epidemiology       Date:  2012-01       Impact factor: 4.822

3.  Associations Between Midlife Vascular Risk Factors and 25-Year Incident Dementia in the Atherosclerosis Risk in Communities (ARIC) Cohort.

Authors:  Rebecca F Gottesman; Marilyn S Albert; Alvaro Alonso; Laura H Coker; Josef Coresh; Sonia M Davis; Jennifer A Deal; Guy M McKhann; Thomas H Mosley; A Richey Sharrett; Andrea L C Schneider; B Gwen Windham; Lisa M Wruck; David S Knopman
Journal:  JAMA Neurol       Date:  2017-10-01       Impact factor: 18.302

4.  Apolipoprotein E polymorphisms predict low density lipoprotein cholesterol levels and carotid artery wall thickness but not incident coronary heart disease in 12,491 ARIC study participants.

Authors:  Kelly A Volcik; Ruth Ann Barkley; Richard G Hutchinson; Thomas H Mosley; Gerardo Heiss; A Richey Sharrett; Christie M Ballantyne; Eric Boerwinkle
Journal:  Am J Epidemiol       Date:  2006-06-07       Impact factor: 4.897

Review 5.  Critically attained threshold of cerebral hypoperfusion: the CATCH hypothesis of Alzheimer's pathogenesis.

Authors:  J C de la Torre
Journal:  Neurobiol Aging       Date:  2000 Mar-Apr       Impact factor: 4.673

6.  Focal hemosiderin deposits and β-amyloid load in the ADNI cohort.

Authors:  Kejal Kantarci; Jeffrey L Gunter; Nirubol Tosakulwong; Stephen D Weigand; Matthew S Senjem; Ronald C Petersen; Paul S Aisen; William J Jagust; Michael W Weiner; Clifford R Jack
Journal:  Alzheimers Dement       Date:  2013-01-30       Impact factor: 21.566

7.  Carotid plaques increase the risk of stroke and subtypes of cerebral infarction in asymptomatic elderly: the Rotterdam study.

Authors:  M Hollander; M L Bots; A Iglesias Del Sol; P J Koudstaal; J C M Witteman; D E Grobbee; A Hofman; M M B Breteler
Journal:  Circulation       Date:  2002-06-18       Impact factor: 29.690

8.  Longitudinal study of carotid atherosclerosis and white matter hyperintensities: the EVA-MRI cohort.

Authors:  Fernando Pico; Carole Dufouil; Claude Lévy; Veronique Besançon; Axel de Kersaint-Gilly; Claire Bonithon-Kopp; Pierre Ducimetière; Christophe Tzourio; Annick Alpérovitch
Journal:  Cerebrovasc Dis       Date:  2002       Impact factor: 2.762

9.  Carotid Intima-Media Thickness and Silent Brain Infarctions in a Biracial Cohort: The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Melissa C Caughey; Ye Qiao; Beverly Gwen Windham; Rebecca F Gottesman; Thomas H Mosley; Bruce A Wasserman
Journal:  Am J Hypertens       Date:  2018-07-16       Impact factor: 3.080

10.  Age-specific and sex-specific prevalence of cerebral β-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50-95 years: a cross-sectional study.

Authors:  Clifford R Jack; Heather J Wiste; Stephen D Weigand; Terry M Therneau; David S Knopman; Val Lowe; Prashanthi Vemuri; Michelle M Mielke; Rosebud O Roberts; Mary M Machulda; Matthew L Senjem; Jeffrey L Gunter; Walter A Rocca; Ronald C Petersen
Journal:  Lancet Neurol       Date:  2017-04-26       Impact factor: 44.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.